<div id="readability-page-1"><div><p>Guobang Pharma Ltd. reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 4,469.88 million compared to CNY 4,418.15 million a year ago. Revenue was CNY 4,469.88 million compared to CNY 4,418.15 million a year ago.</p><p>Net income was CNY 670.24 million compared to CNY 578.88 million a year ago. Basic earnings per share from continuing operations was CNY 1.21 compared to CNY 1.04 a year ago. Diluted earnings per share from continuing operations was CNY 1.21 compared to CNY 1.04 a year ago.</p></div></div>

国邦医药

<p>国邦医药有限公司公布了截至 2025 年 9 月 30 日的九个月财报。公司实现销售额为 44.6988 亿元人民币，较去年同期的 44.1815 亿元人民币有所增长。净收入从去年的 5.7888 亿元人民币上升至 6.7024 亿元人民币。持续经营业务的基本和摊薄每股收益均增加至 1.21 元人民币，而去年为 1.04 元人民币</p>

国邦医药有限公司公布了截至2025年9月30日的九个月财务业绩